# Safety and Efficacy of Mesenchymal Stem Cell for Radiation-induced Hyposalivation and Xerostomia in Previous Head and Neck Cancer Patients

> **NCT04776538** · PHASE2 · UNKNOWN · sponsor: **Rigshospitalet, Denmark** · enrollment: 120 (actual)

## Conditions studied

- Xerostomia Following Radiotherapy

## Interventions

- **BIOLOGICAL:** Stem cells
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT04776538
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-02-09
- **Primary completion:** 2024-03-01
- **Final completion:** 2024-03-01
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2023-09-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04776538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04776538, "Safety and Efficacy of Mesenchymal Stem Cell for Radiation-induced Hyposalivation and Xerostomia in Previous Head and Neck Cancer Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04776538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*